Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Clinica ospedaliero-universitaria Policlinico Umberto I

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Clinica ospedaliero-universitaria Policlinico Umberto I is a historic and highly specialized public teaching hospital located at Viale del Policlinico, 155, 00161 Rome, Italy. Officially opened in 1903 after being championed by notable physicians and politicians like Guido Baccelli, it serves as the primary polyclinic for the Faculty of Medicine and Surgery of the Sapienza University of Rome. Spanning a massive geographic area of over 300,000 square meters with 54 internal buildings, it stands as the largest hospital in Europe by land area and the second-largest public hospital in Italy.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Human-provided. General hospital
Source: Trial-derived.
82Total Trials
Source: Trial-derived.
18Recruiting Trials
Source: Trial-derived.
25Active Trials
Source: Trial-derived.
0Completed Trials
Source: Trial-derived.
108Unique Conditions
Source: Trial-derived.
75Unique Sponsors

Conditions

Source: Trial-derived. Pulmonary Arterial Hypertension (9)Source: Trial-derived. Ovarian Cancer (4)Source: Trial-derived. Breast Cancer (3)Source: Trial-derived. Cardiovascular Diseases (3)Source: Trial-derived. Myelofibrosis (3)Source: Trial-derived. Atrial Fibrillation (2)Source: Trial-derived. Connective Tissue Diseases (2)Source: Trial-derived. Endometrial Cancer (2)

Sponsors

Source: Trial-derived. University of Roma La Sapienza (8)Source: Trial-derived. Mario Negri Institute for Pharmacological Research (5)Source: Trial-derived. Hoffmann-La Roche (4)Source: Trial-derived. Azienda Policlinico Umberto I (3)Source: Trial-derived. Eli Lilly and Company (3)Source: Trial-derived. Fondazione Policlinico Universitario Agostino Gemelli IRCCS (3)Source: Trial-derived. IRCCS Azienda Ospedaliero-Universitaria di Bologna (3)Source: Trial-derived. Pfizer (3)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Six-minute walk test
Source: AI-inferred. CT Scan

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Cardiac catheterisation or electrophysiology procedures
Source: AI-inferred. Lumbar puncture

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Hepatic fat fraction quantification
Source: AI-inferred. Pulmonary function testing
Source: AI-inferred. Tumour PIK3CA mutation testing